
NRx Pharmaceuticals Granted Transfer to Nasdaq Capital Market Amid Key Drug Development Milestones
RADNOR, PA — NRx Pharmaceuticals, Inc., a biopharmaceutical company listed on Nasdaq, has announced that it has been granted permission by The Nasdaq Hearings Panel to transfer its listing to …
NRx Pharmaceuticals Granted Transfer to Nasdaq Capital Market Amid Key Drug Development Milestones Read More